General Information of the Compound
| Compound ID |
CP0437160
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(2R,3R,4S,5R)-2-[6-(4-chloro-2-fluoroanilino)purin-9-yl]-5-[(3,5-dimethylpyrazol-1-yl)methyl]oxolane-3,4-diol
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C21H21ClFN7O3
|
||||||||||||||||||
| Molecular Weight |
473.896
|
||||||||||||||||||
| Canonical SMILES |
Cc1cc(C)n(C[C@H]2O[C@H]([C@H](O)[C@@H]2O)n2cnc3c(Nc4ccc(Cl)cc4F)ncnc23)n1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C21H21ClFN7O3/c1-10-5-11(2)30(28-10)7-15-17(31)18(32)21(33-15)29-9-26-16-19(24-8-25-20(16)29)27-14-4-3-12(22)6-13(14)23/h3-6,8-9,15,17-18,21,31-32H,7H2,1-2H3,(H,24,25,27)/t15-,17-,18-,21-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
GBUQCJFFLQLKRJ-QTQZEZTPSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00840, Adenosine receptor A1
Protein ID: PT00862, Adenosine receptor A2a
Protein ID: PT01278, Adenosine receptor A2b
Protein ID: PT01279, Adenosine receptor A3